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ABSTRACT 
 
 Efficient screening of unknown DNA variations is one of the substantive matters of 
molecular biology even today. Historically, single-strand conformation polymorphism (SSCP) and 
heteroduplex analysis (HA) are the most commonly used methods for detecting DNA variations 
everywhere in the world because of their simplicity. However, the sensitivity of these methods is 
not satisfactory for screening purpose. Recently, several new PCR based mutation screening 
methods have been developed, but most of them require special instruments and adjustment of 
conditions for each DNA sequence to attain the maximum sensitivity, eventually becoming as 
inconvenient as old methods. Enzyme mismatch cleavage (EMC) is potentially an ideal screening 
method. With high performance nucleases and once experimental conditions are optimized, it 
requires only conventional staff and conditions remain the same for each PCR product. In this study 
we tested four commercially available endonucleases for EMC and optimized the electrophoresis 
and developing conditions. We prepared 25 known DNA variations consisting of 18 single base 
substitutions (8 transitions and 10 transversions, including all possible sets of mismatches) and 7 
small deletions or insertions. The combination of CEL nuclease, 12% polyacrylamide gel 
electrophoresis and rapid silver staining can detect all types of mutations and achieved 100% 
sensitivity. 
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1  Introduction 
 
 Determining unknown DNA variations, polymorphisms and mutations, is one of the most 
time consuming steps for DNA based researches, and is important for detecting the causative gene 
mutations for the diagnosis of the Mendelian inherited single gene diseases, detecting the somatic 
mutations of the cancer related genes in the tumor, or list up the single nucleotide polymorphisms to 
determine the association of candidate genes and clinical phenotypes of multifactorial genetic 
diseases. The gold standard for detecting DNA variations in the coding region of the gene of interest 
is to amplify every exon by PCR and perform direct sequencing all of each exon. However, this 
approach is expensive and unacceptably time consuming, especially when the gene of interest has a 
large number of exons and/or the researchers needs to screen a large number of samples or genes. 
Therefore, establishing a simple and effective screening method for unknown DNA variations is one 
of the most compelling problems of molecular biology even today. 
 Historically, PCR based gel shift assays, single-strand conformation polymorphism (SSCP) 
and heteroduplex analysis (HA) were most frequently used for screening of known and unknown 
mutations. Soon after development, these methods spread all over the world because of their 
simplicity, i.e. they are easy to perform in standard laboratories without specific equipment or 
reagents and have high cost performance and high throughput.  
The reported sensitivities of SSCP are highly variable and range 50 to 100% depending on 
the experimental conditions, including gel running temperature, gel and buffer components, DNA 
fragment sizes and mutation sites in the fragments [1, 2]. The sensitivity is usually low when using 
single electrophoresis conditions, about 80% on an average [3-7], and reaches to 95% and higher 
when several different conditions are applied and analyze optimal length fragments [8-11]. DNA 
fragments sizes profoundly affect the SSCP sensitivity. Hayashi [10] described the sensitivity of 
SSCP was 97% when analyzed for 100 to 300 bp segments, though the sensitivity drops to 67% for 
300 to 450 bp. Sheffield et al. [5] also reported the sensitivity of SSCP was changed as fragment 
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size dependently and maximized at approximately 150 bp. It is obvious that SSCP has DNA 
fragment size limitation of < 300 bp to keep the high sensitivity [12]. Because no single condition is 
universally appropriate for all DNA sequence variations in SSCP analysis, researchers are required 
to optimize the condition through the several preparatory experiments for each sequence, or run the 
same samples on several gels with different conditions to obtain the maximum sensitivity. 
 The reported sensitivity of HA is about 80% [13, 14], and analyzed fragment length are 
usually similar to SSCP [15, 16] or slightly longer [13, 17, 18]. HA has often described to have 
lower sensitivity for single base substitution compared to insertion or deletion mutations [19-21]. 
Two modified methods of HA were developed to enhance the migration delay of heteroduplex DNA 
in the gel by changing the gel component or temperature: denaturing gradient gel electrophoresis 
(DGGE) and temperature gradient gel electrophoresis (TGGE) [12]. DGGE uses a gel with a 
gradient of a denaturant, such as urea or hormamide. Heteroduplex DNA is more unstable than 
homoduplex DNA, so it is denatured at lower concentrations of denaturant and thus migrates in the 
gel slowly. Consequently, this gel system enhances the separation of heteroduplex to homoduplex 
DNA. TGGE use the temperature gradient of the gel instead of a denaturant. Similar to DGGE, 
heteroduplex DNA is denatured at lower temperatures than homoduplex, and this system also 
enhances the migration delay of heteroduplex DNA. Although these methods potentially have an 
advantage over HA, they require special equipment for running or making the gel. It could be said 
that these modifications may increased the net sensitivity but sacrifice the convenience of the 
original methods. Thus, these modified methods have not become as popular as the original HA. 
 One clever idea to increase the sensitivity while retaining convenience is to perform SSCP 
and HA simultaneously in the same gel [22, 23]. Because some mutations can be detected only by 
SSCP but not by HA, the converse also being true for other mutations, simultaneous detection 
methods increase the total sensitivity under a single running condition. We have used this SSCP/HA 
approach to screen unknown mutations for several years; however, the detection sensitivity was not 
high enough for our expectations (see results). 
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 The original methods of SSCP and HA have been evolved by several technological 
improvements. It is now possible that labeling PCR products with fluorescent and adapted SSCP 
and HA to automated DNA sequencing machines either slab gel electrophoresis [24-28] or capillary 
electrophoresis (CE) [29-33]. PCR products can be labeled by fluorescent primers [24-26] or 
fluorescent deoxynucleotides either during PCR [27] or after PCR [34, 35]. CE-SSCP offers the 
advantages of being automated, high sensitivity allowing the use of fluorescence detection and also 
achieved high-throughput when adapting multi-capillary system. In addition, several automated CE 
sequencing instrument can apply to SSCP with some minor adjustments [30, 32, 36, 37]. This 
would enable laboratories to reduce their capital equipment expenses by using single instrument for 
both SSCP and sequencing. The sensitivity of CE-SSCP has often been reported to be more than 
90% for fragments with size of 250 bp or smaller [30, 38] and the sensitivity could be increased 
more than 95% by using several different temperatures [32, 39]. These progresses of fluorescent 
labeling and utilizing automated sequencer are also applied to HA [40-42]. Furthermore, Kozlowski 
et al. [43] showed SSCP/HA combined analysis was achieved by CE platform and demonstrated 
100% sensitivity, whereas SSCP and HA alone provided 90 and 81% sensitivity, respectively. Tian 
et al. [42] reported the upper size limit for CE-HA was 200-300 bp. Hence, both SSCP and HA 
remained a drawback of fragment size limitation even use automated CE platform. 
 Electrophoresis on microchip is come to fruition and offers the extraordinary rapid analysis 
system. Tian et al. [33] have demonstrated the ability of microchip SSCP to analyze BRCA1 and 
BRCA2 common mutations less than 120 s. They also explored the potential of microchip HA and 
demonstrated high utility, but concluded fragment size upper limitation was 150-260 bp [42]. 
Microchip electrophoresis seems to offer the best potential in terms of cost effectiveness, rapid 
analysis, and small requirement of sample volumes. However there is still significant work to be 
done to confirm the sensitivity and specificity for applying these methods to general mutation 
screening purpose and still need to overcome the analytical size limitation [12].   
 Recently, several new high sensitivity and high throughput PCR based mutation screening 
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methods other than SSCP and HA have been developed. Some of these require totally new 
instruments and are consequently not becoming popular because of the initial high cost of these 
machines. Among them, one of the relatively prevailing technologies is denaturing 
high-performance liquid chromatography (DHPLC) [44-46]. DHPLC is a type of mobility shift 
assay that does not involve electrophoresis, but instead detects mutations based on the decreased 
retention time of the heteroduplex in an HPLC column. Although this new technology achieves high 
sensitivity, time-consuming optimization of the mutation detection conditions for each DNA 
sequence is still required to obtain the maximum sensitivity [12].  
 Another new and rather experimental technology is matrix assisted laser 
desorption/ionization (MALDI) resequencing [47-50]. Briefly, forward and reverse strands of PCR 
amplifications are selectively transcribed in vitro, enabled by the incorporation of T7 and SP6 
promoter sequences into the 5’ ends of the PCR primers. In separate reactions, both transcripts are 
digested in a controlled manner with RNAses, e.g., specifically cutting after C and U residues, 
respectively. The fragmentation products are then analyzed by MALDI-time of flight (TOF) mass 
spectrometry. Mutations become apparent peaks in the spectra in comparison with the wild type. 
This technology has also achieved high sensitivity but includes cumbersome procedures and cannot 
be applied to relatively long PCR fragments. 
 An ideal mutation screening method would require using only conventional equipments 
and commercially available reagents, a single protocol that can be applied to any DNA sequences 
and mutation types, the ability to handle long PCR fragments, and would achieve high sensitivity, 
high throughput and high cost performance. Based on these criteria, even DHPLC and MALDI, 
which have high sensitivity, are not ideal, because the instruments themselves are too specialized 
and expensive. 
 Another approach to developing a mutation screening method is to cleave the mismatch 
site of the heteroduplex DNA specifically by chemical reagents or single strand specific 
endonucleases. Historically, chemical mismatch cleavage (CMC) was developed first. Briefly, 
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heteroduplex DNA are treated with osmium tetroxide for modifying mismatched thymines, or 
hydroxylamine for modifying mismatched cytosines. After that, modified heteroduplex DNA are 
cleaved by piperidine. This approach first utilized radioisotopes [51, 52] and was then modified to 
use fluorescence and capillary electrophoresis, then called fluorescence-assisted mismatch analysis 
(FAMA) [53-55]. CMC requires separate treatment of the heteroduplex DNA by osmium tetroxide 
and hydroxylamine and further requires ethanol precipitation or other purification of the DNA 
before and after each chemical treatment. Improvements in CMC procedures have been achieved by 
using endonucleases that specifically react to mismatched sites instead of chemicals to cleave 
heteroduplex DNA. 
 This modified method, called enzyme mismatch cleavage (EMC), potentially fulfills the 
criteria of the ideal mutation screening method described above. That is because this method 
requires only conventional staff and does not require adjusting of the conditions for each DNA 
sequence. Heteroduplex DNA is readily cleaved by the enzyme and no need to purify before and 
after treatment by the enzyme. Furthermore, after the DNA segments are cleaved by the enzyme, 
they are physically separated on the gel only based on size alone and not by any other parameters. 
Therefore, there is no need to adjust the gel components or gel running conditions. Thus, if the 
sensitivity of the enzyme for mismatch cleaving is sufficiently high, EMC may become one of the 
ideal mutation screening methods. Recently, there are several reports of EMC using different kinds 
of enzymes [56-63]. Among them CEL nuclease is potentially the most effective enzyme for EMC 
reported recently [64-70] and is now commercially available as SURVEYOR Nuclease S from 
Transgenomic (Omaha, NE, USA) [71-73]. 
 In this study, we prepared 25 known DNA variations, consisting of 18 single base 
substitutions (8 transitions and 10 transversions, including all possible sets of mismatches), 4 small 
deletions and 3 small insertions, for EMC sensitivity analysis. We tested four commercially 
available enzymes, T4 endonuclease VII, endonuclease V, T7 endonuclease I and CEL nuclease 
(SURVEYOR Nuclease S), to compare the sensitivity of EMC with this series of 25 
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mutations/polymorphisms. We also compared the results to our SSCP/HA method previously used 
for mutation screening. In addition, we optimize the gel and gel developing conditions for EMC. 
Identical samples were separated on both agarose and polyacrylamide gels, and the gels were then 
developed with either ethidium bromide, SYBR Green I or silver staining to compare the quality of 
detection. 
 We found that the CEL enzyme achieved perfect sensitivity (100%) and was able to detect 
virtually all types of single base substitutions and any deletion/insertion mutations with the 




2  Materials and methods  
 
2.1  DNA extraction and PCR 
 
 DNA samples were obtained from the patients and their family members in the department 
of pediatrics, Kanazawa University Hospital. The subjects had known specific gene mutations or 
polymorphisms determined by previous molecular analysis, and their DNA changes were confirmed 
by PCR direct sequencing of both forward and reverse sequences using a BigDye Terminator v3.1 
cycle sequencing kit and an ABI PRISM 3100 Genetic analyzer (Applied Biosystems, Foster City, 
CA, USA). The nucleotide changes are summarized in Table 1. The nucleotide number of each gene 
is according to GenBank accession AF013168, X75621, NM_000487 and NM_004895 for TSC1, 
TSC2, ARSA and CIAS respectively. DNA samples were also obtained from healthy volunteers as a 
normal control, and their DNA sequence was confirmed by direct sequencing. After an explanation 
of this study, written informed consent was obtained from all of the subjects. This study was 
approved by the ethics committee of the Kanazawa University Graduate School of Medical Science. 
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 Peripheral blood leukocyte DNA was extracted by a rapid method according to Lahiri et al. 
[74, 75]. Extracted DNA samples were diluted by 1X TE (10mM Tris-HCl, 1mM Na2EDTA at pH 
7.8) to 0.1μg/μl for use as the PCR template. PCR primers used in this study and corresponding 
genes are listed in Table 1. All PCR reactions were performed under the same single condition: 
0.2μM of each primer, 10mM Tris-HCl (pH 8.4), 50mM KCl, 2.0mM MgCl2, and 0.1 unit Taq DNA 
polymerase (Roche, Grenzacherstrasse, Switzerland) in 5μl of reaction volume. Cycle parameters 
were 94oC for 5 min (initial denaturation), followed by 30 cycles of 95oC for 10 sec and 58oC for 10 
sec, and ending with 72oC for 3 min (final extension). 
 
2.2  Heteroduplex formation and enzyme mismatch cleavage 
 
 After PCR cycles, heteroduplex DNA were successively produced on a thermal cycler 
using the following conditions: 85oC for 15 min and 97oC for 5 min, for complete denaturation of 
the PCR products, followed by a reduction in the temperature to 25 oC by -1 oC per min. 
  We compared four different endonucleases for EMC: T4 endonuclease VII (500U/ul, usb, 
Cleveland, OH, USA), Endonuclease V (10000U/ml, New England BioLabs, Ipswich, MA, USA), 
T7 endonuclease I (10000U/ml, New England BioLabs) and CEL enzyme (SURVEYOR Nuclease 
S, Transgenomic, Omaha, NE, USA).  
One μl of heteroduplex substrate was incubated with each enzyme and each reaction buffer 
in a total reaction volume of 5μl. The reactions were performed at 42oC for SURVEYOR Nuclease 
S and at 37oC for the other three enzymes. We tested two incubation time for each heteroduplex as 
short time (20min) and long time (3h). Each enzyme, T4 endonuclease VII, Endonuclease V, T7 
endonuclease I, and SURVEYOR Nuclease S, was added to the reactions at 250U, 5U, 5U and 
0.25μl for 20min digestion and 25U, 0.5U, 0.5U and 0.05μl for 3h digestion, respectively. 
 The content of each of the reaction buffers is described below. T4 endonuclease VII 
reaction buffer is 50mM Tris-HCl (pH 8.0), 10mM MgCl2, 10mM β-ME, 0.5μg/μl bovine serum 
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albumin (BSA);  the Endonuclease V reaction buffer is 20mM Tris-acetate (pH 7.9), 50mM 
potassium acetate, 10mM magnesium acetate, 1mM dithiothreitol (DTT); the T7 endonuclease I 
reactions buffer is 10mM Tris-HCl (pH 7.9), 50mM NaCl, 10mM MgCl2, 1mM dithiothreitol 
(DTT); and the SURVEYOR Nuclease S reaction buffer is 10mM Tris-HCl (pH 8.4), 50mM KCl, 
2.0mM MgCl2. The first three enzyme buffers were prepared according to manufactures’ 
instructions, while the SURVEYOR Nuclease S reaction buffer is the same as the PCR reaction 
buffer. 
 
2.3  SSCP / HA method 
 
 SSCP and HA can detect in the same gel simultaneously. We modified the methods of 
Axton et al. for standard slab gel PAGE [23]. In our protocol, after PCR amplification of the 
specific DNA sequences, 5μl of SSCP/HA solution (95% formamide, 150mM NaOH, and 0.02% 
bromophenol blue (BPB)) was added to 5μl of the PCR reaction solution. The mixture was heated 
with the thermal cycler at 99oC for 5 min and then quickly cooled on ice for 15 min. All samples 
were loaded on a SSCP/HA gel (12% polyacrylamide (Acr/Bis = 49:1, 8% glycerol)) and run at 
15V/cm for 2h at room temperature in 1X TBE (100 mM Tris-HCl (pH 8.0), 83mM boric acid, and 
1mM Na2EDTA). The gel was developed with an optimized silver staining procedure described 
below. 
 Using this protocol, approximately half of the PCR products assume a single stranded 
conformation while the rest are double stranded DNA in hetero- or homoduplex form. Because 
double stranded DNA runs faster than single stranded DNA, the lower part of the gel showed HA, 
and at the same time the upper part of the gel showed SSCP analysis (Figure 1). 
 
2.4  Electrophoresis and developing the gel 
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 To compare band separation ability and developing sensitivity, we performed four identical 
mismatch cleavage reactions, each with a five μl reaction volume, with CEL enzyme for all 25 DNA 
variations. Two of them were mixed with one μl of gel loading buffer (50% glycerol, 10mM 
Tris-HCl (pH 8.0), 0.1% SDS, 3mM EDTA, 0.02% BPB) and run on the 3% agarose gels (NuSieve 
3:1, Cambrex Bio Science, Rockland, ME, USA) for 30 min at 100V in 1X TBE. The remaining 
two samples were mixed with 5μl of glycerol loading buffer (50% glycerol, 5mM Tris-HCl (pH 7.8), 
0.5mM EDTA, 0.02% BPB) and run on 12% polyacrylamide gels (Acr/Bis = 19:1, 8% glycerol; 
200mm x 105mm x 1mm, with 37 wells) for 90min at 15V/cm in 1X TBE. Therefore, a total of four 
gels were run separately. The agarose gels were then developed with ethidium bromide or SYBR 
Green I (Invitrogen, Carlsbad, CA, USA), and the polyacrylamide gels were developed with SYBR 
Green I or silver staining for comparison. After electrophoresis, agarose gels were transferred to a 
container with 1X TBE and ethidium bromide (to 1μg/ml) or SYBR Green I (to a 1:10000 dilution) 
were added. The gel was stained with adequate agitation for 20 min at room temperature, and the 
DNA bands were then detected under the UV transilluminator. For SYBR Green I, a SYBR 
Green/Gold photographic filter (Invitrogen) was used to take pictures. One polyacrylamide gel was 
stained with SYBR Green I and detected in the same way. The remaining polyacrylamide gel was 
developed by silver staining. We used an optimized silver staining method described by Ji et al. [76], 
with the following modifications. After electrophoresis, the gel was rinsed in deionized water 
briefly and then incubated in 0.1% AgNO3 (w/v) for 5min at room temperature with gentle agitation. 
The AgNO3 solution was reclaimed, and the gel was quickly rinsed with deionized water three 
times. The gel was then incubated with 0.04% Na2CO3 (w/v), 0.5% NaOH (w/v), and 0.2ml 37% 
HCOH per 100ml solution was added to for 3 to 5min at room temperature to develop the gel. After 
developing a sufficient intensity of the bands, the gel was rinsed with deionized water briefly, and 
the reaction was stopped with 1% acetic acid. All of these four gels were compared with regard to 
sensitivity and quality for each sample (Figure 2).  
 According to the results of this comparison, all subsequent T4 endonuclease VII, 
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endonuclease V and T7 endonuclease I EMC samples were run on 12% polyacrylamide gels and 
developed by silver staining. Also, all SSCP/HA gels were developed by silver staining. 
 
 
3  Results 
 Under our conditions, we observed no mismatch cleavage by T4 endonuclease VII and 
endonuclease V in any type of mutation/polymorphism prepared for this study (Figure 3). We 
re-tested with a 10 fold higher concentration of these enzymes with 10μl and 25μl of reaction 
volume for digesting one μl of heteroduplex DNA and increased the incubation time to 24h; 
however, again no cleavage was confirmed. T7 endonuclease I detected several 
mutations/polymorphisms, and the CEL enzyme detected all of the 25 DNA variations. For these 
two enzymes, both 20min digestion with high titer enzyme and 3h digestion with low titer enzyme 
were equally effective, and no difference in the results was observed. When using low titer enzyme, 
nonspecific or over digestions were not observed until at least 24h. Results of detection for each 
DNA variation by each method are listed in Table 2, and overall sensitivities are summarized in 
Table 3. 
 In SSCP / HA screening, more single base substitutions were detected by SSCP than HA, 
and more insertion/deletion mutations were detected by HA than SSCP. SSCP and HA complement 
each other in the detection of DNA variations, and the use of them together increases the sensitivity 
compared to each method alone. However, the total sensitivity of SSCP / HA method remained at 
52% (Table 3). T7 endonuclease I can detect all insertion/deletion mutations and 61% of single base 
substitutions (63% of transitions and 60% of transversions) with a total sensitivity of 72%. Under 
our conditions, the CEL enzyme had 100% total sensitivity and was able to detect all single base 
substitutions and insertion/deletion mutations of the 25 different DNA variations. Apparently, CEL 
mediated EMC is superior to T7 endonuclease I or SSCP/HA analysis (Figure 1, 4). 
 Comparing T7 endonuclease I to CEL nuclease reveals that CEL can detect more single 
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base substitutions than T7 endonuclease I. CEL can cleave all transitions and transversions which 
can not be cleaved by T7 endonuclease I. On the other hand, insertion/deletion mutations seemed to 
be more clearly cleaved by T7 endonuclease I than CEL nuclease (Figure 4). However, both 
enzymes cleaved all insertion/deletion mutations, and their detection sensitivity was not different. 
 Cleaved DNA segments were more clearly separated on polyacrylamide gel compared with 
agarose gel. Also, some cleaved bands, especially those representing single base substitutions, were 
very faint and difficult to discern in agarose gel. In agarose gel, SYBR Green I staining did not 
increase the detection sensitivity compared to ethidium bromide staining. Silver staining and SYBR 
Green I staining of polyacrylamide gels was better than agarose gels, and silver staining most surely 
and easily detected the cleaved band (Figure 2).  
 
 
4  Discussion 
 
 Detecting unknown DNA variations is one of the key steps in many areas of genetic 
research. To date, many mutation screening methods have been invented, but no one method 
satisfies both simplicity and high sensitivity for screening purposes. Recently, totally new 
equipment, such as CE-SSCP/HA, DHPLC and MALDI, has been introduced to this field. Methods 
utilizing this equipment demonstrate high sensitivity and high throughput, but none have become 
widely used because of the high cost of these machines. The current tendency that a few heavily 
equipped laboratories with expensive specialized equipment create a monopoly of high throughput 
mutation analysis is undesirable for the further progress of molecular biology. Since virtually every 
researcher studying DNA needs to detect mutations or polymorphisms in some steps of their work, 
there is an increasing need for the development of easy to use, highly sensitive and high cost 
performance methods for the massive majority of scientists working in laboratories with standard 
equipment. 
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 Historically, SSCP and HA lead in this field, but generational change is at the gate. 
Actually, these methods have several disadvantages. HA has a relatively low sensitivity for single 
base substitutions, and both HA and SSCP have size limit on the fragments that can be analyzed. In 
fact, current studies show that SSCP/HA analysis detects only 52% of DNA variations. HD and 
SSCP detect only two and five single base substitutions, respectively. Previous data from our group 
showed a nearly 60% of mutation detecting ability for screening the mutation unknown patient 
populations of tuberous sclerosis complex (TSC) using the same methods [77, 78]. It seems that the 
present study included relatively large size PCR products which reduced SSCP/HA sensitivity. 
 Enzyme mismatch cleavage (EMC) is one of the breakthroughs of mutation screening 
strategies. EMC may actually become an ideal method with the recently discovered neutral pH 
DNA endonucleases isolated from celery, the CEL nuclease family. There are several reports that 
EMC using CEL I nuclease demonstrates a very high sensitivity [70, 73]. According to Qiu et al. 
[71], the SURVEYOR Nuclease S corresponds to CEL II nuclease, a putative isozyme of CEL I 
nuclease [65]. EMC can be applied to longer PCR fragments compared to SSCP and HA [69, 70]. 
Qiu et al. analyzed 2.95-kb heteroduplex DNA by Surveyor nuclease [71].  In general,  SSCP is 
thought to be most sensitive in detecting mutations when the fragment size is shorter than 200bp, 
and the size limit for high sensitivity is 300bp [1], even using CE-SSCP [12]. This size limitation 
produces a cost and effort disadvantage when analyzing long exons, i.e. more PCR primers and 
more PCR reactions are required. To overcome the size limitation, a new method combining 
dideoxyfingerprinting and SSCP, named “detection of virtually all mutation-SSCP” (DOVAM-S), 
was developed [79-81]. However, DOVAM-S requires several gel running conditions to attain 
detection of virtually all mutations, making it relatively inconvenient as well. On the other hand, 
CEL mediated EMC can be applied to long segments of more than 1kb. Because this size exceeds 
the length of limitation of standard direct sequencing, it could be said that EMC extends the 
analytical length enough for PCR based mutation screening. 
 We tested four commercially available endonucleases for EMC. Among them, we detected 
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no mismatch cleavage by T4 endonuclease VII and endonuclease V. In our protocol, PCR products 
are readily convert to heteroduplex and cleaved by enzyme without any purification. Therefore, 
purification of heteroduplex DNA may be necessary before cleaving by T4 endonuclease VII and 
endonuclease V. Nonetheless, a purification step is not desireable for a simple procedure, and we do 
not want to use these enzymes for EMC. CEL nuclease and T7 endonuclease I showed clear 
mismatch incision without any purification steps. In terms of overall sensitivity, CEL nuclease is 
clearly better than T7 endonuclease I, mainly for the better sensitivity to single base substitutions.  
 There are two major groups of single base substitutions, transitions and transversions. 
Transitions is defined as one of the purines (A or G) is converted to the other purine (G or A) or one 
of the pyrimidines (T or C) is converted to the other pyrimidine (C or T). However, in fact, because 
purines are paired to pyrimidines in the double-strand DNA, when interchange of purines are 
happened in the one strand of the DNA, at the same time in the complementary strand, interchange 
of pyrimidines are occurred, and vice versa. Therfore, ignore the sense and anitisense direction of 
double stranded DNA and avoid duplication, transition can be simplified to the interchange of A:T 
base pair and G:C base pair in one allele of the gene. Then, possible mismatches of the 
heteroduplex DNA formed with wild type allele and substituted allele are A/C and G/T. Another 
type of single base substitution is the transversion. Transversion is defined as a purine is converted 
to a pyrimidine or vice versa. In this situation, one of the purines (A or G) is converted to a 
pyrimidine (C or T) in one strand of the DNA, and in the complementary strand, one of the 
corresponding pyrimidines (T or C) is converted to a purine (G or A) simultaneously. Thus, the 
possible conversion set of base pairs is, ignore the DNA strand direction and after simplification, 
A:T to C:G, A:T to T:A and G:C to C:G (note G:C to T:A is equivalent to A:T to C:G). Accordingly, 
the possible mismatches formed in the heteroduplex DNA are A/G, C/T, A/A, T/T, C/C, and G/G. In 
both transition and transversion, one single base substitution causes a pair of heteroduplexes. In 
summary, four possible single base substitutions, one transition A to G (T to C in the 
complementally strand) and three transversions A to C (T to G), A to T (T to A) and G to C (C to G), 
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cause four possible pairs of heteroduplexes; A/C and G/T, A/G and C/T, A/A and T/T, and C/C and 
G/G. (see also Table 2). CEL I nuclease can cleave all of these mismatches. However, CEL I does 
demonstrate some substrate preference, as C/C was cleaved the most, T/T was cleaved least, and 
other mismatches were cleaved intermediately [64]. On the other hand, T7 endonuclease I is also 
said to cleave all type of mismatches; however, its properties have not been well studied [58, 62]. In 
our mutation/polymorphism collection, CEL nuclease could cleave all 18 single base substitutions, 
including three transitions and four transversions which were not cleaved by T7 endonuclease I. 
These 18 single base substitutions included all types of base pair changes and mismatches described 
above. These results proved that CEL nuclease based EMC can be applied to detect any kind of 
single base substitutions.  
Interestingly, there was some tendency for T7 endonuclease I to cleave deletion/insertion 
heteroduplex more readily than CEL nuclease (Figure 4). These results may reflect a difference in 
the nature of each endonuclease. Technically, CEL nuclease also cleaved deletions/insertions 
mutations very well, and heteroduplex DNA formed by large deletions/insertions of more than 10bp 
could migrate slowly in polyacrlylamide gel thereby allowing for HA and assist in mutation 
detection (I3 in Figure 4). Therefore, this type of cleavage limitation does not truly affect the total 
sensitivity of CEL mediated EMC when using a polyacrylamide gel. 
 In the separation and developing of the cleaved DNA fragments, some cleaved band were 
very faint or not well separated and thus difficult to detect in agarose gel. This could not be 
overcome by staining the agarose gel with SYBR Green I instead of ethidium bromide. SYBR 
Green I stains DNA bands more brightly than ethidum bromide, but it usually does not help to pick 
out the shorter bands from the large majority of un-cleaved bands. This is because band separation 
is poor in agarose gels in general. Fragment separation in polyacrylamide gel is better than agarose 
gel, and silver staining of polyacrylamide gels was diplayed higher sensitivity than SYBR Green I 
staining. Furthermore, silver staining has other advantages over SYBR Green I staining. Silver 
stained gels can be kept for long time in nylon packs at 4˚C, and the cleaved band is always visible 
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to the naked eye with ambient light. According to Beidler et al. [82] silver staining of 
double-stranded DNA is at least 100 times as sensitive as fluorescence staining with ethidium 
bromide. In principle, the optical density of silver stained double stranded DNA in a polyacrylamide 
gel is proportional to DNA amount before the band density is saturated [82, 83, 86]. However, 
Goldman et al. [83] found the greater staining of smaller DNA fragments relative to larger ones by 
silver staining. The increasing rate of the band intensity per DNA increment is similar for pieces of 
DNA larger than 300 bp, but is greater for fragments of smaller size. Additionally, the optical 
density of larger DNA fragments saturate faster than smaller fragments [83], as a result, smaller 
fragments can be stained appropriately without burning out of larger bands. Based on this property, 
silver staining can stains smaller bands more effectively or stains more equally throughout the 
different size of the fragments comparing to ethidium bromide staining [82, 84, 85]. This 
characteristic feature of silver staining is perfectly fit to EMC. It makes easy to detect the small size 
fragments produced by mismatch cleavage and also make easy to distinguish the cleaved bands not 
so mach shorter than the un-cleaved wild type fragments. Many people think silver staining is an 
inconvenient, complicated and time consuming method for detection, but the optimized silver 
staining methods by Ji et al. [76]. are easy and extraordinarily convenient, requiring the use of few 
reagents and less than 10min to complete. Thus, we recommend polyacrlamide gel electrophoresis 
and silver staining as a routine protocol for mutation detection systems. 
 EMC showed very high performance with a standard slab gel system, but this method can 
also be applied to new technologies, such as capillary electrophoresis with fluorescence or 
semiautomatic high throughput machines like the WAVE system (Transgenomic, Omaha, NE, USA). 
Thus, a CEL nuclease based EMC system could be widely used in any type of laboratory and may 
spread worldwide as the next trend in molecular genetics. 
 In this study, using only conventional equipment belonging to a basic laboratory and 
commercially available reagents and enzyme, we showed that CEL nuclease mediated EMC can 
detect any kind of DNA variation with very high sensitivity, no need to adjust the experimental 
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protocol to each DNA sequence, applicable to long PCR fragments, and high cost performance (less 
than 15 cents per sample when using low titer enzyme). Also, this EMC method is possible to apply 
to fluorescence automated sequencer [64, 65, 87] and CE platform [73] according to your laboratory 
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Table 1. Nucleotide changes and PCR primers 
 
Index Gene Ex/In Nucleotide change Forward Primer Reverse Primer 
TS1 TSC1 In 3 IVS3+15A>G gaaccttcagaacctgtagc cagcaggattctagtggctc 
TS2 TSC1 In 16 IVS16+1G>A gaccacaaggaagtgatctaac aaccatgtgggctggatttg 
TS3 TSC1 In 19 IVS19+51A/G gaaagtagagccgttgagct ccatgacacagacactcaagt
TS4 TSC2 In 15 IVS15-15G>A tgctgactcagaaccatgag ctggtggacgctagccatg 
TS5 TSC2 Ex 27 3273C>T, G1091G caacttcacggctgtcccg tgtcgaggctggcaggcg 
TS6 TSC2 Ex 40 5228G>A, R1743Q tggccaagatcgtgtctgac gacaggcaataccgtccaag
TS7 ARSA Ex 6 1424A>G, N350S cttgatggcgaactgagtga aggtcaaagccatccaagg 
TS8 CIAS Ex 3 1478A>G, A242A aggagctgcaccttccatt agtgcagagcggtcctatgt 
TV1 TSC2 In 39 IVS39-9C>A tggccaagatcgtgtctgac gacaggcaataccgtccaag
TV2 CIAS In 8 IVS8+44A>C cagcatacaaggctgcttga caggcccaacctaatcttga 
TV3 TSC2 Ex 12 1348G>T, E450X caacaccggctcttcttttg tgccaggcaaggctacagag
TV4 TSC2 In 28 IVS28+2T>G gactaagtcaccctgtgcgt ccagcagcaactgagggag
TV5 ARSA In 7 IVS7+20C>G gcggactggaaagtacaagg tgagcagtcagagagctgga
TV6 TSC2 Ex 36 4713C>G, Y1571X ttgtctgcctcagggatcag ggggtagcaggactggatg 
TV7 TSC1 Ex 19 2646G>C, E809E gaaagtagagccgttgagct ccatgacacagacactcaagt
TV8 TSC2 Ex 16 1796A>T, K599M gtgctgtcttaggactgcg gtctctgcagcttccaggaa 
TV9 TSC2 Ex 39 5110T>A, S1704T gctgcagtgtggcgccaaga gagctcactatcaggtggca 
TV10 TSC1 Ex 15 2104T>A, L628X attgccaaagacagcccatc aggtgggagtgtgaagaatg
D1 ARSA In 3 IVS3-3delC gtgacccctacccagtgcta agatgaccagcgtctcttcaa
D2 TSC1 In 15 IVS15+67-68delAG attgccaaagacagcccatc aggtgggagtgtgaagaatg
D3 TSC2 Ex 30 3620-3624delGCTGG agatgggtaaggggaggtac ggagcagagcccgtgccaa
D4 TSC2 Ex 40 5238-5255del (18bp del) tggccaagatcgtgtctgac gacaggcaataccgtccaag
I1 ARSA Ex 2 1190-1191insC gtatcggaaagagcctgctg cctacctggtcgtgggagta 
I2  TSC2 Ex 10 980-981insAT gcagctctgaccctgtgtgc tggccgagcctgcctgtct 
I3 TSC2 Ex 33 4159-4160insCCTGAGCA
AGTCCAGCT (17bp ins) 
ctgacaggggttctctttgg tccagggtccctgactgtga 
 
Nucleotide number of each gene is according to GenBank accession AF013168, X75621, 
NM_000487 and NM_004895 for TSC1, TSC2, ARSA and CIAS respectively. 
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mismatch Size (bp) Mut/Poly 
position 
SSCP/HA T7EI CEL 
Single base substitution      
Transition       
TS1 A>G G/T, A/C 241 180 N / N Y Y 
TS2 G>A A/C, G/T 185 145 N / N Y Y 
TS3 A>G G/T, A/C 332 278 N / N Y Y 
TS4 G>A A/C, G/T 276 48 N / N N Y 
TS5 C>T T/G, C/A 298 142 N / Y N Y 
TS6 G>A A/C, G/T 493 220 Y / N Y Y 
TS7 A>G G/T, A/C 142 117 Y / N Y Y 
TS8 A>G G/T, A/C 681 453 N / N N Y 
Transversion       
TV1 C>A A/G, C/T 361 144 N / N Y Y 
TV2 A>C C/T, A/G 444 366 N / N Y Y 
TV3 G>T T/C, G/A 158 114 N / N Y Y 
TV4 T>G G/A, T/C 245 152 Y / N Y Y 
TV5 C>G G/G, C/C 217 59 Y / N N Y 
TV6 C>G G/G, C/C 379 169 N / Y Y Y 
TV7 G>C C/C, G/G 391 181 N / N N Y 
TV8 A>T T/T, A/A 276 143 Y / N Y Y 
TV9 T>A A/A, T/T 212 97 N / N N Y 
TV10 T>A A/A, T/T 317 51 N / N N Y 
Deletion or Insertion      
D1 1bp del 1bp bubble 197 40 Y / N Y Y 
D2 2bp del 2bp bubble 267 231 N / Y Y Y 
D3 5bp del 5bp bubble 296 63 Y / Y Y Y 
D4 18bp del 18bp bubble 583 227 N / Y Y Y 
I1 1bp ins 1bp bubble 305 253 N / N Y Y 
I2 2bp ins 2bp bubble 241 45 N / Y Y Y 
I3 17bp ins 17bp bubble 301 189 Y / Y Y Y 
 
Y, detected; N, not detected; In the SSCP/HA column, results of SSCP are indicated on the left side 
and HA results are indicated on the right side. 
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Table 3. Sensitivity 
 
 SSCP/HA T7EI CEL 
Single base substitution 7/18 (39) 11/18 (61) 18/18 (100) 
Transition 3/8 (38) 5/8 (63) 8/8 (100) 
Transversion 4/10 (40) 6/10 (60) 10/10 (100) 
Insertion + Deletion 6/7 (86) 7/7 (100) 7/7 (100) 
All 13/25 (52) 18/25 (72) 25/25 (100) 
 
Numbers in each box show detected / screened nucleotide changes (percentage) 
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Comparing SSCP/HA and CEL enzyme mediated EMC. Band shift of SSCP/HA are indicated by 
white arrow heads, and cleaved bands by CEL are indicated by black arrow heads. Nucleotide 
changes indicated by index, TV1, TS6 and I2 are listed in Table 1. ss, single strand DNA; ds, double 
strand DNA. S, samples with mutation; C, wild type control. 
 
Figure 2 
Comparing gel and developing conditions of CEL enzyme mediated EMC. Cleaved bands by 
enzymes are indicated by black arrow heads. Index of nucleotide changes are according to Table 1. 
PS, polyacrylamide gel with silver staining; PG, polyacrylamide gel with SYBR Green I staining; 
AE, agarose gel with ethidium bromide staining; AG, agarose gel with SYBR Green I staining. S, 
samples with mutation; C, wild type control.  
 
Figure 3 
Example of comparison of four enzymes for EMC. Cleaved band (indicated by black arrow heads) 
can be confirmed in CEL (SURVEYOR nuclease S) and T7 (T7 endonuclease I) but not in EV 
(Endonuclease V) and T4VII (T4 endonuclease VII). TS6 and D1 indicate DNA mutations 
described in Table 1. S, samples with mutation; C, wild type control. 
 
Figure 4  
Example comparing CEL nuclease and T7 endonuclease I mediated EMC. Cleaved bands by 
enzymes are indicated by black arrow heads and band shift by heteroduplex formation are indicated 
by white arrow heads. Index of nucleotide changes are according to Table 1. S, samples with 
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